Safety and Efficacy of Eculizumab in Neuromyelitis Optica

This chapter explores the safety and efficacy of eculizumab for treating neuromyelitis optica spectrum disorders, referencing insights from a cohort study on infection risks. It highlights the importance of individual patient factors in treatment decisions, while acknowledging the drug's effectiveness in reducing relapses and stabilizing patients.